Journal of Clinical Epidemiology
Volume 58, Issue 6 , Pages 609-617 , June 2005

The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid

,Accepted 25 November 2004.

References 

  1. Douglas RM. Respiratory tract infections as a public health challenge. Clin Infect Dis. 1999;28:192–194
  2. Dingle JH, Badger GF, Jordan WS. Illness in the home: a study of 25,000 illnesses in a group of Cleveland families. Cleveland, OH: The Press of Western Reserve University; 1964;
  3. Gwaltney JM, Hendley JO, Simon G, Jordan WS. Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med. 1966;275:1261–1268
  4. Monto AS, Ullman BM. Acute respiratory illness in an American community: the Tecumseh study. JAMA. 1974;227:164–169
  5. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–494
  6. Smith MBH, Feldman W. Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991. JAMA. 1993;269:2258–2263
  7. Turner RB. The treatment of rhinovirus infections: progress and potential. [Review] Antiviral Res. 2001;49:1–14
  8. Jackson GG, Dowling HF, Anderson TO, Riff L, Saporta J, Turck M. Susceptibility and immunity to common upper respiratory viral infections: the common cold. Ann Intern Med. 1960;55:719–738
  9. Jackson GG, Dowling HF, Muldoon RL. Acute respiratory diseases of viral etiology. VII. Present concepts of the common cold. Am J Public Health. 1962;52:940–945
  10. Gwaltney JM. Rhinovirus colds: epidemiology, clinical characteristics and transmission. Eur J Respir Dis Suppl. 1983;128:336–339
  11. Barrett B, Locken K, Maberry R, Schwamman J, Brown R, Bobula J, et al. The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold. J Fam Pract. 2002;51:265;Available at: http://www.fammed.wisc.edu/wurss/
  12. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press; 1996;
  13. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994;47:81–87
  14. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ. 1986;134:889–894
  15. Guyatt G, Walter S, Norman G. Measuring change over time: Assessing the usefulness of evaluative instruments. J Chron Dis. 1987;40:171–178
  16. Samsa G. How should the minimum important difference for a health-related quality-of-life instrument be estimated?. Med Care. 2001;39:1037–1038
  17. Wells G, Anderson J, Beaton D, Bellamy N, Boers M, Bombardier C, et al. Minimal clinically important difference module: summary, recommendations, and research agenda. J Rheumatol. 2001;28:452–454
  18. Wright JG. The minimal important difference: who's to say what is important?. J Clin Epidemiol. 1996;49:1221–1222
  19. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407–415
  20. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol. 1996;49:1215–1219
  21. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77:371–383
  22. Kroonenberg PM, Lewis C. Methodological issues in the search for a factor model: exploration through confirmation. J Educ Stat. 1982;7:69–89
  23. Joreskog KA. Statistical analysis of sets of congeneric tests. Psychometrika. 1971;36:109–133
  24. Bollen KA. Structural equations with latent variables. New York: Wiley; 1989;
  25. Agresti A. Categorical data analysis. 1st ed.. New York: Wiley; 1990;
  26. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991;
  27. Thorndike RM. Correlational procedures for research. New York: Gardner Press; 1978;
  28. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443–450
  29. Arruda E, Pitkäranta A, Witek TJ, Doyle CA, Hayden FG. Frequency and history of rhinovirus infections in adults during autumn. J Clin Microbiol. 1997;35:2864–2868
  30. Gwaltney JM. Virology and immunology of the common cold. Rhinology. 1985;23:265–271
  31. Gwaltney JM. Rhinoviruses. In:  Evans AS,  Kaslow RA editor. Viral infections of humans: epidemiology and control. 4th ed.. New York: Plenum Medical Book Company; 1997;p. 815–838
  32. Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78:531–539
  33. Gwaltney JM, Buier RM, Rogers JL. The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold. Antiviral Res. 1996;29:287–295
  34. Kleinman A. Medicine's symbolic reality: on a central problem in the philosophy of medicine. Inquiry. 1973;16:206–213
  35. Ware JE, Kosinski M, Dewey JE, Gandek B. How to score and interpret single-item health status measures: a manual for users of the SF-8 health survey. Lincoln, RI: QualityMetric; 2001;

PII: S0895-4356(04)00349-X

doi: 10.1016/j.jclinepi.2004.11.019

Journal of Clinical Epidemiology
Volume 58, Issue 6 , Pages 609-617 , June 2005

Article Tools

* Image Usage & Resolution